Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

News

      Lilly’s neutralizing antibody bamlanivimab receives interim authorization from Health Canada as a treatment for COVID-19

      Drug Development
      Health Canada granted authorization under the Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19 for the...

      Catalent Signs Commercial Supply Agreement with Blueprint Medicines Following FDA Approval of GAVRETO

      FDA Approvals
      Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products,...

      Baxter Invests $50M to Expand Sterile Fill/Finish Manufacturing Operations

      News
      Baxter International Inc. has announced a $50 million expansion of its sterile fill/finish manufacturing facilities located in Bloomington, IN. These facilities are operated by...

      Lonza and Be The Match BioTherapies Enter CGT Partnership

      News
      Be The Match BioTherapies, an organization offering solutions for companies developing and commercializing cell and gene therapies (CGT), and Lonza have entered a partnership...

      Moderna and Pfizer COVID Vaccines: Key Things to Know

      Drug Development
      The COVID-19 pandemic has made us witness both. With so much taking place in the medical & the health fraternity across the globe,  we...

      Australia begins production of Oxford Covid-19 vaccine, plans to manufacture 30 million doses

      Manufacturing
      A Covid-19 vaccine co-developed by pharmaceutical company AstraZeneca and the University of Oxford is seen as one of the most promising of all the...

      CCRM and McMaster Innovation Park (MIP) Partner to Buildand Operate Biomanufacturing Campus

      Drug Development
      CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies, and McMaster Innovation Park (MIP), Canada's Premier Innovation Park,...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

      System

      Resources

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.